Literature DB >> 22130447

Evaluation of macrophage-specific promoters using lentiviral delivery in mice.

M C Levin1, U Lidberg, P Jirholt, M Adiels, A Wramstedt, K Gustafsson, D R Greaves, S Li, S Fazio, M F Linton, S-O Olofsson, J Borén, I Gjertsson.   

Abstract

In gene therapy, tissue-specific promoters are useful tools to direct transgene expression and improve efficiency and safety. Macrophage-specific promoters (MSPs) have previously been published using different delivery systems. In this study, we evaluated five different MSPs fused with green fluorescent protein (GFP) to delineate the one with highest specificity using lentiviral delivery. We compared three variants of the CD68 promoter (full length, the 343-bp proximal part and the 150-bp proximal part) and two variants (in forward and reverse orientation) of a previously characterized synthetic promoter derived from elements of transcription factor genes. We transduced a number of cell lines and primary cells in vitro. In addition, hematopoietic stem cells were transduced with MSPs and transferred into lethally irradiated recipient mice. Fluorescence activated cell sorting analysis was performed to determine the GFP expression in different cell populations both in vitro and in vivo. We showed that MSPs can efficiently be used for lentiviral gene delivery and that the 150-bp proximal part of the CD68 promoter provides primarily macrophage-specific expression of GFP. We propose that this is the best currently available MSP to use for directing transgene expression to macrophage populations in vivo using lentiviral vectors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22130447      PMCID: PMC3697098          DOI: 10.1038/gt.2011.195

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  27 in total

Review 1.  Seventeen-colour flow cytometry: unravelling the immune system.

Authors:  Stephen P Perfetto; Pratip K Chattopadhyay; Mario Roederer
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

Review 2.  Transcription factors, normal myeloid development, and leukemia.

Authors:  D G Tenen; R Hromas; J D Licht; D E Zhang
Journal:  Blood       Date:  1997-07-15       Impact factor: 22.113

3.  Multiple Ets factors and interferon regulatory factor-4 modulate CD68 expression in a cell type-specific manner.

Authors:  Dawn O'Reilly; Carmel M Quinn; Tariq El-Shanawany; Siamon Gordon; David R Greaves
Journal:  J Biol Chem       Date:  2003-04-03       Impact factor: 5.157

4.  Scavenger receptor A gene regulatory elements target gene expression to macrophages and to foam cells of atherosclerotic lesions.

Authors:  A Horvai; W Palinski; H Wu; K S Moulton; K Kalla; C K Glass
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

Review 5.  Physiological and tissue-specific vectors for treatment of inherited diseases.

Authors:  M G Toscano; Z Romero; P Muñoz; M Cobo; K Benabdellah; F Martin
Journal:  Gene Ther       Date:  2010-10-21       Impact factor: 5.250

6.  High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter.

Authors:  Christophe Demaison; Kathryn Parsley; Gaby Brouns; Michaela Scherr; Karin Battmer; Christine Kinnon; Manuel Grez; Adrian J Thrasher
Journal:  Hum Gene Ther       Date:  2002-05-01       Impact factor: 5.695

7.  Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice.

Authors:  S Bellosta; R W Mahley; D A Sanan; J Murata; D L Newland; J M Taylor; R E Pitas
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

8.  The CD11b promoter directs high-level expression of reporter genes in macrophages in transgenic mice.

Authors:  S Dziennis; R A Van Etten; H L Pahl; D L Morris; T L Rothstein; C M Blosch; R M Perlmutter; D G Tenen
Journal:  Blood       Date:  1995-01-15       Impact factor: 22.113

9.  Gene therapy of apolipoprotein E-deficient mice using a novel macrophage-specific retroviral vector.

Authors:  Peter J Gough; Elaine W Raines
Journal:  Blood       Date:  2002-09-05       Impact factor: 22.113

10.  Macrophage apolipoprotein A-I expression protects against atherosclerosis in ApoE-deficient mice and up-regulates ABC transporters.

Authors:  Yan Ru Su; Hiroyuki Ishiguro; Amy S Major; Dwayne E Dove; Wenwu Zhang; Alyssa H Hasty; Vladimir R Babaev; MacRae F Linton; Sergio Fazio
Journal:  Mol Ther       Date:  2003-10       Impact factor: 11.454

View more
  9 in total

1.  Macrophage-specific overexpression of interleukin-5 attenuates atherosclerosis in LDL receptor-deficient mice.

Authors:  W Zhao; T Lei; H Li; D Sun; X Mo; Z Wang; K Zhang; H Ou
Journal:  Gene Ther       Date:  2015-04-14       Impact factor: 5.250

Review 2.  Engineering humanized mice for improved hematopoietic reconstitution.

Authors:  Adam C Drake; Qingfeng Chen; Jianzhu Chen
Journal:  Cell Mol Immunol       Date:  2012-03-19       Impact factor: 11.530

3.  Strategy of STAT3β cell-specific expression in macrophages exhibits antitumor effects on mouse breast cancer.

Authors:  W Dang; H Tang; H Cao; L Wang; X Zhang; W Tian; X Pang; K Li; T Chen
Journal:  Gene Ther       Date:  2015-10-01       Impact factor: 5.250

4.  Lentiviral gene therapy using cellular promoters cures type 1 Gaucher disease in mice.

Authors:  Maria Dahl; Alexander Doyle; Karin Olsson; Jan-Eric Månsson; André R A Marques; Mina Mirzaian; Johannes M Aerts; Mats Ehinger; Michael Rothe; Ute Modlich; Axel Schambach; Stefan Karlsson
Journal:  Mol Ther       Date:  2015-02-06       Impact factor: 11.454

5.  A macrophage-specific synthetic promoter for therapeutic application of adiponectin.

Authors:  W S Kang; J S Kwon; H B Kim; H-Y Jeong; H J Kang; M H Jeong; J G Cho; J C Park; Y S Kim; Y Ahn
Journal:  Gene Ther       Date:  2014-02-06       Impact factor: 5.250

6.  Lentiviral vectors containing mouse Csf1r control elements direct macrophage-restricted expression in multiple species of birds and mammals.

Authors:  Clare Pridans; Simon Lillico; Bruce Whitelaw; David A Hume
Journal:  Mol Ther Methods Clin Dev       Date:  2014-04-09       Impact factor: 6.698

7.  Engineering monocyte/macrophage-specific glucocerebrosidase expression in human hematopoietic stem cells using genome editing.

Authors:  Samantha G Scharenberg; Edina Poletto; Katherine L Lucot; Pasqualina Colella; Adam Sheikali; Thomas J Montine; Matthew H Porteus; Natalia Gomez-Ospina
Journal:  Nat Commun       Date:  2020-07-03       Impact factor: 14.919

8.  Simplified production and concentration of lentiviral vectors to achieve high transduction in primary human T cells.

Authors:  Adam P Cribbs; Alan Kennedy; Bernard Gregory; Fionula M Brennan
Journal:  BMC Biotechnol       Date:  2013-11-12       Impact factor: 2.563

9.  In vitro study on human umbilical cord mesenchymal stem cells transfected with lentivirus-mediated hNIS-EGFP dual reporter gene and co-labeled with superparamagnetic iron oxide.

Authors:  Yu Meng; Huanhuan Liu; Ning Bian; Jian Gong; Xing Zhong; Chunrong Huang; Wenxue Liang; Hao Xu
Journal:  Exp Ther Med       Date:  2018-07-23       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.